Tokushima, Japan

Yoshikazu Oka



Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yoshikazu Oka

Introduction

Yoshikazu Oka is a notable inventor based in Tokushima, Japan. He has made significant contributions to the pharmaceutical field, particularly in the stabilization and absorption of drug preparations. With a total of 2 patents, Oka's work has the potential to enhance the efficacy of various medications.

Latest Patents

Oka's latest patents include a method for stabilizing pharmaceutical preparations and a cilostazol preparation. The first patent discloses a method for stabilizing a solid pharmaceutical preparation containing a pharmacological substance and sodium lauryl sulfate. This method incorporates neutral salts, basic salts, and basic substances to improve storage stability, suppress discoloration, and maintain the properties of the preparation. The second patent focuses on a cilostazol preparation that enhances the dispersibility and solubility of cilostazol, improving its absorbability in the lower portion of the digestive tract. This innovation allows cilostazol to be effective as a thrombolytic drug and cerebral circulation improving agent.

Career Highlights

Yoshikazu Oka is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing methods that improve drug formulations and their effectiveness.

Collaborations

Oka has collaborated with notable colleagues such as Tadashi Mukai and Yuso Tomohira. Their combined expertise has contributed to the advancement of pharmaceutical technologies.

Conclusion

Yoshikazu Oka's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving drug formulations and patient outcomes. His work continues to influence the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…